Copper peptides are widely used in anti-aging skincare, but one objection appears repeatedly:
“Peptides are too large to penetrate the skin, so topical copper peptides can't actually work.”
It sounds convincing. The skin is designed to keep outside substances out, and peptides generally have characteristics that make topical delivery difficult.
But when it comes specifically to GHK-Cu, the evidence does not support such a simple yes-or-no answer.
Experimental studies have shown that copper delivered as GHK-Cu can penetrate and remain within human skin. At the same time, the amount that travels through different skin layers can vary dramatically, and researchers still consider topical GHK-Cu delivery an important formulation challenge.
So the better question is not simply:
“Does GHK-Cu penetrate?”
It is:
How much penetrates, where does it go, what affects its delivery, and is that enough to produce meaningful effects in real human skin?
Why Is Skin Penetration Difficult?
The outermost portion of the epidermis is called the stratum corneum.
It is often described using a “brick-and-mortar” model:
- Corneocytes act like the bricks
- Lipids surrounding them act like the mortar
Together, they form an extremely effective barrier that reduces water loss while limiting the entry of outside substances.
This presents a particular challenge for many peptides.
GHK-Cu is relatively hydrophilic, meaning it interacts readily with water. The stratum corneum, however, contains a highly organized lipid environment.
That mismatch makes passive movement through the barrier more difficult. Recent reviews therefore describe GHK-Cu as having limited permeability through the lipophilic stratum corneum, rather than simply declaring it unable to penetrate at all.
What Exactly Is GHK-Cu?
GHK is a naturally occurring tripeptide composed of three amino acids:
Glycine + Histidine + Lysine
When it binds copper, the resulting complex is known as GHK-Cu.
In cosmetic ingredient labeling, it is generally identified as Copper Tripeptide-1.
GHK-Cu has been studied for biological activities involving tissue repair, extracellular-matrix remodeling, antioxidant processes, and pathways related to collagen and other structural components of skin.
Those biological properties make skin delivery important.
If a topical peptide cannot reach a biologically relevant location, strong activity observed in cultured cells may have limited relevance to a finished skincare product.
Has GHK-Cu Been Tested on Human Skin?
Yes.
One particularly useful experiment evaluated penetration of a copper tripeptide through different layers of human cadaver skin over 48 hours.
Researchers separately studied:
- Isolated stratum corneum
- Isolated epidermis
- Dermatomed skin containing multiple layers
The results were dramatically different depending on which skin barrier was present.
What Did the Study Find?
The permeability coefficient for GHK-Cu varied enormously depending on the skin layer.
Across isolated epidermis, penetration was extremely low.
Across dermatomed skin, measurable transport occurred.
Across isolated stratum corneum, substantially greater apparent transport was measured—but this simplified system lacked deeper skin layers that can retain or alter the copper complex.
After 48 hours, the percentage of the applied copper dose detected beyond the isolated epidermis was only about 0.006%.
That sounds tiny.
But measuring what crosses completely through a skin sample is not the same thing as measuring what remains inside the skin.
And for a topical skincare ingredient, retention within skin tissue may actually be relevant.
GHK-Cu Can Be Retained Within Skin
The same human-skin research found increased copper retention within the tested skin layers following exposure to the copper peptide complex.
Researchers proposed that GHK-Cu may partially dissociate after entering the skin, allowing copper to interact with endogenous molecules already present in tissue.
This distinction is important.
A topical ingredient does not necessarily need to travel completely through the skin and enter systemic circulation to have a local cosmetic effect.
For many skincare ingredients, the desired target is within the epidermis or dermis, not beyond the skin.
So a study finding little material in the receiver compartment does not automatically mean that nothing entered or remained in the skin.
Does GHK-Cu Cross Completely Through Human Skin?
Not necessarily—and newer research illustrates why terminology matters.
A recent study tested several tripeptides using human skin in Franz diffusion cells. GHK-Cu was evaluated both in aqueous solution and in liposomal delivery systems.
After 24 hours, researchers detected no tested peptide in the receiver solution, meaning none was demonstrated to pass completely through the skin sample under those experimental conditions.
That does not contradict earlier evidence showing penetration and retention within skin.
The two findings can coexist:
A substance can enter portions of the skin without traversing the entire skin sample.
That is precisely why statements such as “GHK-Cu penetrates” and “GHK-Cu doesn't penetrate” can both become misleading when stripped of context.
Penetration Is Not the Same as Transdermal Absorption
These terms are often used interchangeably online, but they describe different things.
Skin penetration can mean movement of a substance into one or more layers of the skin.
Permeation generally refers to movement through a barrier.
Transdermal absorption implies movement through the skin sufficiently to reach the systemic circulation.
A cosmetic peptide designed to act locally in skin does not necessarily need meaningful systemic absorption.
In fact, systemic delivery is generally not the objective of a topical cosmetic serum.
So asking whether GHK-Cu “gets through the skin” may be the wrong benchmark.
A more relevant question is whether enough biologically intact peptide—or its active components—reaches the appropriate skin compartment.
And that remains incompletely characterized.
Does Molecular Size Prevent GHK-Cu From Penetrating?
Molecular size matters, but it isn't the only factor.
Skin permeation depends on several physicochemical properties, including:
- Molecular weight
- Lipid solubility
- Water solubility
- Electrical charge
- Molecular structure
- Concentration
- Vehicle
- Skin condition
GHK-Cu's hydrophilic nature is a particular challenge because the stratum corneum favors movement of relatively lipophilic substances.
But the published evidence demonstrates that saying “peptides cannot penetrate because they're too large” is an oversimplification.
Different peptides behave differently, and chemical modifications can substantially alter penetration.
Reviews of GHK and its derivatives have reported greater permeability for modified forms such as Pal-GHK, in which a lipid-soluble palmitoyl group is attached to the peptide.
Why the Formulation Matters
A percentage printed on a serum bottle tells you how much ingredient went into the formula.
It does not tell you how much ultimately reaches a biologically relevant location in skin.
The formulation surrounding GHK-Cu can affect:
- Peptide stability
- Solubility
- Release from the vehicle
- Interaction with the stratum corneum
- Retention within skin
- Availability of the peptide after application
That is why topical-delivery research increasingly investigates carrier systems rather than evaluating the active ingredient alone.
Can Liposomes Help GHK-Cu Penetrate?
Liposomes are microscopic structures composed of lipid bilayers.
Because they can encapsulate both water-soluble and lipid-soluble substances, they have long been investigated as delivery systems for cosmetic and pharmaceutical ingredients.
Researchers have successfully incorporated GHK-Cu into stable liposomal systems.
But an important distinction remains:
Successfully putting GHK-Cu inside a liposome does not automatically prove that the liposome delivers it deeply into human skin.
A 2025 review concluded that despite substantial interest in liposomal GHK-Cu, actual skin-permeation data remain surprisingly limited.
And the more recent human-skin experiment discussed above did not detect GHK-Cu crossing completely through the tissue even when liposomes were used.
What About Microneedles?
Microneedling changes the problem because it temporarily creates physical pathways through the stratum corneum.
Researchers have therefore proposed microneedle-assisted delivery as one potential way to increase penetration of peptides that otherwise have difficulty crossing intact skin.
However, that is fundamentally different from normal application of a cosmetic serum.
Research reviews identify microneedling as a promising area for enhanced peptide delivery, but this should not be interpreted as proof that applying GHK-Cu immediately after an at-home needling procedure is necessarily beneficial or appropriate.
Does More GHK-Cu Solve the Penetration Problem?
Not necessarily.
This connects directly with another common misconception about peptide products.
Increasing a serum from 0.1% to 1% GHK-Cu increases the amount applied to the skin, but it does not automatically increase biologically useful delivery by the same factor.
The stratum corneum remains a barrier.
Other formulation factors may become limiting.
And importantly, there are not strong human dose-response studies establishing exactly how topical GHK-Cu concentration translates into clinical outcomes.
That's why concentration and delivery should be evaluated separately.
If Penetration Is Limited, Does Topical GHK-Cu Still Make Sense?
Potentially, yes.
Limited penetration is not the same thing as zero penetration.
Human-skin experiments demonstrate measurable movement and retention of copper associated with GHK-Cu under certain conditions.
But we also need to keep the evidence hierarchy straight.
There is a difference between demonstrating:
The ingredient can enter skin
and demonstrating:
A finished topical product reliably produces clinically meaningful anti-aging changes in people.
The latter requires controlled human clinical studies.
And that evidence remains considerably thinner for GHK-Cu than the popularity of copper peptides might suggest.
A recent review specifically noted the surprising shortage of published clinical trials evaluating GHK-Cu for wrinkle reduction despite its widespread cosmetic use.
What Does This Mean for Copper Peptide Serums?
There are several practical conclusions.
First, it is incorrect to say that topical GHK-Cu cannot penetrate skin at all.
Second, it is equally incorrect to assume that every serum containing Copper Tripeptide-1 delivers meaningful quantities to deeper skin layers.
Third, a high percentage alone does not guarantee superior delivery.
And fourth, formulation quality matters.
When evaluating a copper peptide serum, useful questions include:
- Does it identify the actual peptide?
- Is the concentration disclosed?
- Is the peptide stable in the formulation?
- Is the vehicle appropriate?
- Are the claims proportional to the available evidence?
Those questions are more informative than simply asking whether “peptides penetrate.”
The Bottom Line
GHK-Cu can penetrate and be retained within human skin under experimental conditions.
But penetration varies substantially depending on the skin layer, formulation, experimental conditions, and what researchers actually define as penetration.
GHK-Cu is hydrophilic, which makes movement through the lipid-rich stratum corneum challenging. Experimental evidence nevertheless shows measurable skin entry and retention, while newer research confirms that complete passage through intact human skin can remain extremely limited.
So neither extreme is supported:
“GHK-Cu cannot penetrate skin.” — too simplistic.
“GHK-Cu easily penetrates deeply into skin.” — also not established.
The more accurate conclusion is that topical delivery is possible but limited and highly formulation-dependent—and considerable research is still needed to determine how delivery translates into real-world clinical results.
Related Research
What Percentage of GHK-Cu Is Effective in Skincare? →
Topical GHK-Cu vs. Injectable GHK-Cu: What Does the Evidence Actually Show? →
Copper Peptides for Skin: What Does the Research Actually Show? →
Scientific References
- Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflammation Research. 2010. Human ex-vivo skin study evaluating GHK-Cu penetration and retention.
- Mazurowska L, Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. Journal of Cosmetic Science. 2008;59(1):59–69.
- Ogórek K, Nowak K, Wadych E, et al. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? Molecules. 2025;30(1):136.
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. Review of GHK/GHK-Cu permeability and clinical evidence.
- Ogórek K, et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application. Research on GHK-Cu encapsulation and potential topical-delivery systems.
- Tripeptide-Loaded Liposomes as Multifunctional Components in Topical Formulations. Human-skin Franz-cell permeation research including GHK-Cu as a reference peptide.
